heart failure
Conditions
Interventions
Western medicine section:? Drug treatment plan: The conventional treatment of western medicine is given ACEI/ARB or ARNI, ß-blockers, aldosterone receptor antagonists, and diuretics, digitalis, SGLT-2
Chinese medicines section:On the basis of conventional treatment in the Western medicine group, Shengmai SAN combined with Danggui Shaoyao SAN was given in the traditional Chinese medicine group for t
Chinese medicine + guidance group:On the basis of TCM group treatment, the State General Administration of Sport password version of Baduanjin training was given.
Sponsors
The Third Affiliated Hospital of Zhejiang Chinese Medicine University
Eligibility
Sex/Gender
All
Age
18 Years to 79 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria of HFrEF; (2) Age = 18 years old =79 years old (male or female); (3) Grade II-III cardiac function; (4) Sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with acute coronary syndrome who had acute myocardial infarction or underwent revascularization in the early stage (within 2 days) or within the last 6 months; (2) aortic/aorta parietal tumor; (3) Fatal arrhythmias; (4) acute heart failure (hemodynamic instability); (5) Uncontrolled hypertension after medication (systolic blood pressure =160mmHg and/or diastolic blood pressure =100mmHg); (6) pericardial diseases such as constrictive pericarditis; (7) Cardiomyopathy: severe hypertrophic obstructive cardiomyopathy, restrictive cardiomyopathy; (8) acute systemic cardiomyopathy; (9) pulmonary embolism; (10) primary pulmonary hypertension; Cerebral infarction in recent 3 months; (11) mentally ill persons; (12) Moderate to severe anemia (hemoglobin <90g/L); (13) severe hepatic and renal insufficiency (alanine transaminase =3 times the normal upper limit, serum creatinine =3mg/dl); (14) Participants who have participated in other clinical trials within the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| peakVO2/kg;anaerobic threshold;Diaphragmatic thickening rate;Degree of diaphragm movement;left ventricular ejection fraction;NT-proBNP; | — |
Countries
China
Contacts
Public ContactLIU QIANG
The Third Affiliated Hospital of Zhejiang Chinese Medicine University
Outcome results
None listed